← Back
Data updated: Jun 28, 2026
CYPRESS PHARM
Generics Pharmaceuticals
CYPRESS PHARM is a generic drug manufacturer with 5 FDA-approved products.
2008
Since
5
Drugs
-
Trials
0
New Drugs (2yr)
CYPRESS PHARM's Key Drugs
CYPRESS PHARM's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CYPRESS PHARM's Recent FDA Approvals
New NDA/BLA approvals for CYPRESS PHARM over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CYPRESS PHARM's Therapeutic Areas
Disease areas where CYPRESS PHARM has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CYPRESS PHARM Pipeline Snapshot
Active clinical trials for CYPRESS PHARM across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2008-10-10
- Latest
- 2017-11-28
- Applications
- 5
FDA Sponsor Names
CYPRESS PHARMCYPRESS PHARM INC